Oxidative Medicine and Cellular Longevity / 2015 / Article / Tab 3

Research Article

Body Composition, Lipid Profile, Adipokine Concentration, and Antioxidant Capacity Changes during Interventions to Treat Overweight with Exercise Programme and Whole-Body Cryostimulation

Table 3

Hematological indices changes following the exercise programme.

Parameters
Min–maxMin–maxMin–maxMin–maxMin–max

RBC 1012/L4.84 ± 0.443.85–5.894.88 ± 0.404.19–5.653.87 ± 1.04 
2.83–8.694.41 ± 0.34 
3.83–4.964.76 ± 0.34 
4.23–5.28

HGB mmol/L7.60 ± 0.736.5–8.87.67 ± 0.676.60–9.47.08 ± 1.11 
5.10–11.47.02 ± 0.75 
4.70–8.57.13 ± 0.75 
4.9–8.3

HCT L/L0.40 ± 0.040.33–0.480.41 ± 0.040.36–0.50.33 ± 0.07 
0.26–0.730.37 ± 0.04 
0.27–0.450.40 ± 0.04 
0.30–0.46

MCV fL83.7 ± 4.3270–9284.40 ± 3.7477–9284.32 ± 4.3370–9284.26 ± 4.768–9083.27 ± 4.7665–90

MCH fmol1.55 ± 0.111.19–1.731.56 ± 0.081.38–1.721.87 ± 0.23 
1.30–2.151.81 ± 0.13 
1.21–1.791.46 ± 0.11 
1.08–1.65

MCHC mmol/L18.52 ± 0.3917.1–19.118.51 ± 0.4617.70–19.622.17 ± 2.09 
15.60–24.219.15 ± 0.48 
17.7–2017.52 ± 0.43 
16.5–18.7

RDW %12.86 ± 1.1410.9–16.312.84 ± 0.8911.20–15.615.11 ± 1.44 
12.7–2114.11 ± 0.99 
12.90–17.213.65 ± 1.13 
12.4–17.6

WBC 109/L7.45 ± 1.255.00–9.76.95 ± 1.264.60–9.86.91 ± 1.085.20–9.46.49 ± 1.26  
4.7–9.27.04 ± 1.484.8–10.4

LYM 109/L2.59 ± 0.561.80–3.82.41 ± 0.571.60–3.72.51 ± 0.61.60–3.92.40 ± 0.661.4–4.52.45 ± 0.621.5–4.6

MON 109/L0.51 ± 0.130.30–0.80.53 ± 0.210.20–1.20.47 ± 0.120.2–0.70.41 ± 0.130.2–0.70.46 ± 0.140.2–0.8

GRA 109/L4.35 ± 1.042.60–6.24.00 ± 0.95 2.10–6.43.94 ± 0.862–5.83.68 ± 0.752.30–4.94.12 ± 1.192.9–7.5

PLT 109/L248.64 ± 79.9129–520231.88 ± 58.41120–345208.52 ± 88.3115–549228.3 ± 59126–357252.89 ± 79.78159–521

RBC: red blood cells; HB: hemoglobin; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW: red blood cell distribution width; WBC: white blood cells; LYM: lymphocytes; MON: monocytes; GRA: granulocytes; PLT: thrombocytes.
Significance of differences at ≤ 0.05 versus before.
Significance of differences at ≤ 0.01 versus before.
Significance of differences at ≤ 0.001 versus before.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.